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Introduction
Since 1983, as the leading cause of death [1], cancer has become a
major public health concern in Korea. Annually, over 190,000 patients
are newly diagnosed with cancer in Korea, and one out of four deaths is
due to cancer [2,3]. Although the cancer registration system in Korea is
very efficient and can provide nationwide cancer statistics within a rela-
tively short time, at least a 2-year lag is still required for accurate data col-
lection and compilation. To plan and apply a cancer control program, it is
important to assess the number of new cases and deaths that are expected
to occur during the current year. In this report, we provide the projected
cancer incidence and mortality ratio based on the data up to 2009.
M ate rials  and  M ethods
The Korean Ministry of Health and Welfare initiated a nationwide, hos-
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Purpose
To estimate the current cancer burden in Korea, cancer incidence and mortality rates were pro-
jected for the year 2012.
Materials and Methods
The cancer incidence data from 1999 to 2009 were obtained from the Korea National Cancer In-
cidence Database, and the cancer mortality data from 1993 to 2010 were obtained from Statistics
Korea. Cancer incidence in 2012 was projected by fitting a linear regression model on observed
age-specific cancer incidence rates against observed years, then multiplying the projected age-
specific rates by the age-specific population. For cancer mortality, a similar procedure was ap-
plied, except that a Joinpointregression model was used to determine at which year the linear
trend significantly changed.
Results
A total of 234,727 new cancer cases and 73,313 cancer deaths are projected to occur in Korea in
2012. For all sites combined, the crude incidence rates are projected to be 465.6 and 459.7, and
the age-standardized incidences to be 345.1 and 300.9 per 100,000 respectively for males and fe-
males.
Conclusion
Cancer has become an important public health concern in Korea, and as the Korean population
ages, the cancer burden will continue to increase.
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in 1980. The details of the history, objectives, and activities of the KCCR
have been documented elsewhere [4]. Incidence data from 1999 to 2009
were obtained from the Korea National Cancer Incidence Database
(KNCI DB). Cancer cases were classified according to the International
Classification of Diseases for Oncology, 3rd edition [5] and converted ac-
cording to the International Classification of Diseases, 10th edition (ICD-
10) [6].
Mortality data from 1993 to 2010 were obtained from Statistics Korea
[1]. The cause of death was coded and classified according to ICD-10.
The cancer sites included in this report are (i) all cancers combined and
(ii) the 22 most common cancers: lip, month, and pharynx (C00-C14),
esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and
intrahepatic bile duct (liver) (C22), gallbladder and other parts of biliary
tract (gallbladder) (C23-C24), pancreas (C25), lung and bronchus (lung)
(C33-C34), breast (C50), uterine cervix (C53), uterine corpus (C54), ovary
(C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain
and central nervous system (C70-C72), thyroid (C73), Hodgkin lym-
phoma  (C81),  non-Hodgkin  lymphoma  (C82-C85,  C96),  multiple
myeloma (C90), leukemia (C91-C95), and all others.
Population data were obtained from the resident registration population
reported by Statistics Korea. The mid-year population on July 1 of the re-
spective year was applied when computing the incidence and deaths.  
Due to the time required for data collection and analysis, incidence and
mortality data are available is usually 2-3 years behind the current year.
As such, we projected the expected number of new cancer cases and
deaths in Korea in the current year to provide an estimate of the current
cancer burden.
Linear regression models [7] were used to assess the time trend and the
projection of rates. Based on the observed cancer incidence data, a linear
regression model was fitted to the age-specific rates by 5-year age group
against observed years. From the projected age-specific rates in 2012, the
estimated number of cancer cases was calculated by multiplying the rates
by 2012’s projected age-specific population size. For thyroid and prostate
cancer, which showed significant curvilinear trends, we used a square root
transformation when fitting a linear regression model and converted the
predicted values back to the original scale.
To estimate the number of cancer deaths in 2012, we first ran a Join-
point regression model on the data for 1993-2010 to detect the year of
significant changes in the trend of cancer mortality by sex and cancer site.
A Joinpoint regression describes changes in data trends by connecting
several different line segments on a log scale at “joinpoints.” This analysis
was performed using the Joinpoint software (version 3.3, http://srab.can-
cer.gov/joinpoint) from the Surveillance Research Program of the National
Cancer Institute in the USA [8]. After identifying the year of significant
trend changes using Joinpoint regression analysis, a simple linear regres-
sion model was fitted to the last line segment to estimate age-specific can-
cer mortality rates in 2012. Similar to the method used for the projection
of cancer incidence, the number of new deaths was then projected by mul-
tiplying the age-specific cancer mortality rates by 2012’s projected age-
specific population.
We summarized the results using the crude rates (CRs) and age-stan-
dardized rates (ASRs) of cancer incidence and mortality. The ASRs were
standardized using the World Health Organization (WHO) world standard
population [9].
Results
1. Incidence
Table 1 presents the estimated number of new cancer cases and deaths
during 2012 in Korea by sex and cancer site. It is projected that 234,727
cases of cancer incidence will occur in 2012.
Table 2 presents the estimated CRs and ASRs of cancer incidence in
2012 by sex and cancer site. The CRs of all sites combined in males and
females respectively in 2012 are projected to be 465.6 and 459.7 per
100,000, and the ASRs of all sites combined are projected to be 345.1 and
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Fig. 1. The 10 leading types of estimated new cancer cases and deaths by gender in 2012. (A) Estimated new cases. (B) Estimated deaths.
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300.9 per 100,000. In males, the five leading primary sites of cancer are
expected to be the stomach (CR, 86.8; ASR, 63.2), colon and rectum (CR,
77.4; ASR, 56.7), lung (CR, 62.9; ASR, 46.6), liver (CR, 49.5; ASR, 35.6),
and prostate (CR, 43.4; ASR, 32.5), accounting for 68.7% of all newly
diagnosed cancers in 2012. In females, the most common cancer sites are
expected to be thyroid (CR, 153.4; ASR, 109.4), breast (CR, 64.6; ASR,
44.1), colon and rectum (CR, 49.5; ASR, 29.5), stomach (CR, 41.1; ASR,
24.7), lung (CR, 26.6; ASR, 14.7), and liver (CR, 17.1; ASR, 10.0), ac-
Table 1. Estimated new cancer cases and deaths by gender during 2012 in Korea
CNS, central nervous system. a)Includes gallbladder and other/unspecified parts of the biliary tract.
Estimated new cases Estimated deaths
Sites
Both genders Male Female Both genders Male Female
All sites 234,727 118,304 116,423 73,313 45,356 27,957
Lip, oral cavity, and pharynx 2,801 2,102 699 1,024 754 270
Esophagus 2,262 2,075 187 1,223 1,139 84
Stomach 32,455 22,054 10,401 8,685 5,630 3,055
Colon and rectum 32,215 19,669 12,546 8,195 4,648 3,547
Liver 16,910 12,585 4,325 10,973 8,186 2,787
Gallbladdera) 5,481 2,697 2,784 3,884 1,879 2,005
Pancreas 5,396 2,911 2,485 4,663 2,445 2,218
Larynx 1,077 1,036 41 226 210 16
Lung 22,737 15,991 6,746 16,168 11,819 4,349
Breast 16,436 63 16,373 2,146 16 2,130
Cervix uteri 3,292 - 3,292 819 - 19
Corpus uteri 2,085 - 2,085 259 - 259
Ovary 2,124 - 2,124 987 - 987
Prostate 11,016 11,016 - 1,540 1,540 -
Testis 215 215 - 18 18 -
Kidney 4,310 2,949 1,361 846 558 288
Bladder 3,969 3,185 784 1,026 737 289
Brain and CNS 1,837 975 862 1,061 575 486
Thyroid 46,021 7,158 38,863 360 100 260
Hodgkin lymphoma 253 160 93 41 26 15
Non-Hodgkin lymphoma 4,506 2,502 2,004 1,493 865 628
Multiple myeloma 1,236 648 588 841 424 417
Leukemia 2,885 1,609 1,276 1,676 964 712
Other and ill defined 13,208 6,704 6,504 5,159 2,823 2,336
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Fig. 2. Projected age-specific incidences of major cancers during 2012 in Korea. (A) Male. (B) Female.
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counting for 76.7% of all newly diagnosed cancers (Fig. 1). Thyroid can-
cer alone is projected to account for 33.4% (38,863 cases) of incident
cases in females in 2012.
Table 3 presents the most common cancer sites expected in 2012 by
sex and age group. Leukemia and thyroid cancer are projected to be the
most common forms of cancer in both sexes for the 0-14 and 15-34 age
Table 2. Estimated crude and age-standardized cancer incidences by gender during 2012 in Korea
CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/un-
specified parts of biliary tract.
Crude incidence rates/100,000 Age-standardized incidence rates/100,000a)
Both genders Male Female Both genders Male Female
All sites 462.7 465.6 459.7 312.5 345.1 300.9
Lip, oral cavity, and pharynx 5.5 8.3 2.8 3.8 6.0 1.9
Esophagus 4.5 8.2 0.7 2.9 6.1 0.4
Stomach 64.0 86.8 41.1 42.1 63.2 24.7
Colon and rectum 63.5 77.4 49.5 41.9 56.7 29.5
Liver 33.3 49.5 17.1 22.0 35.6 10.0
Gallbladderb) 10.8 10.6 11.0 6.7 7.9 5.7
Pancreas 10.6 11.5 9.8 6.7 8.4 5.3
Larynx 2.1 4.1 0.2 1.4 3.0 0.1
Lung 44.8 62.9 26.6 28.2 46.6 14.7
Breast 32.4 0.2 64.6 22.2 0.2 44.1
Cervix uteri 6.5 - 13.0 4.4 - 8.5
Corpus uteri 4.1 - 8.2 2.8 - 5.5
Ovary 4.2 - 8.4 3.0 - 5.8
Prostate 21.7 43.4 - 14.1 32.5 -
Testis 0.4 0.8 - 0.4 0.8 -
Kidney 8.5 11.6 5.4 5.9 8.5 3.5
Bladder 7.8 12.5 3.1 4.9 9.2 1.6
Brain and CNS 3.6 3.8 3.4 3.1 3.4 2.7
Thyroid 90.7 28.2 153.4 64.5 20.1 109.4
Hodgkin lymphoma 0.5 0.6 0.4 0.4 0.5 0.3
Non-Hodgkin lymphoma 8.9 9.8 7.9 6.4 7.7 5.4
Multiple myeloma 2.4 2.6 2.3 1.6 1.9 1.4
Leukemia 5.7 6.3 5.0 5.1 6.0 4.4
Other and ill defined 26.0 26.4 25.7 18.1 20.7 15.9
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Fig. 3. Projected age-specific mortality rates of major cancers during 2012 in Korea. (A) Male. (B) Female.
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groups. Gastric cancer is predicted to be the most common cancer in males
35-64 years of age, whereas lung cancer is predicted to be more frequent
for malese ≥65 years of age. Thyroid cancer is predicted to be the most
common cancer for females 35-64 years of age, whereas colorectal cancer
is predicted to be the most common cancer for females ≥65 years of age.
Fig. 2 shows the age-specific incidence rates of the selected cancers for
men and women in 2012. The projection indicates that the incidence of
gastric, lung, liver, and colorectal cancers will increase gradually with age.
In women, the age-specific incidence rates of breast and thyroid cancer
will increase with age until the 5th and 6th decades of life, and then level
off.
2. Mortality
It is estimated that 73,313 cancer deaths will occur in Korea during
2012 (Table 1). The CRs of all sites combined in 2012 respectively for
males and females are projected to be 178.5 and 110.4 per 100,000, and
the ASRs of all sites combined are expected to be 135.8 and 59.0 per
100,000 (Table 4).
In 2012, the five leading cancer sites causing mortality in males are
predicted to be lung (CR, 46.5; ASR, 34.4), liver (CR, 32.2; ASR, 23.5),
stomach (CR, 22.2; ASR, 16.4), colon and rectum (CR, 18.3; ASR, 13.7),
and pancreas (CR, 9.6; ASR, 7.1). During the same time period, in fe-
males, lung cancer (CR, 17.2; ASR, 8.7) is projected to be the leading
cancer site causing mortality, followed by cancers of the colon and rectum
(CR, 14.0; ASR, 7.1), stomach (CR, 12.1; ASR, 6.1), liver (CR, 11.0;
ASR, 6.0), and pancreas (CR, 8.8; ASR, 4.5).
Fig. 3 shows the age-specific predicted mortality rates of the selected
cancers for males and females in 2012. When examined by age, Korean
males > 60 years of age are expected to have the highest mortality rates
from liver cancer, followed by lung cancer. In contrast, Korean females >
55 years of age are expected to have the highest mortality rates from breast
cancer, followed by lung cancer.
C onclusion
This report provides the estimated nationwide cancer incidence and
mortality in Korea for the current year. A total of 234,727 new cancer
cases and 73,313 cancer deaths are expected in Korea during 2012. In
Korean males, gastric, colorectal, lung, liver, and prostate cancers are es-
timated to have the highest rates of incidence, while lung, liver, gastric,
colorectal, and pancreatic cancers are estimated to be the most common
causes of cancer-related deaths. In Korean females, thyroid, breast, col-
orectal, gastric, and lung cancer are estimated to have the highest rates of
Table 3. Estimated cancer incidence by age group and sex during 2012 in Korea
CNS, central nervous system.
Age group (yr)
Rank
0-14 15-34 35-64 ≥65
Male
1 Leukemia Thyroid Stomach Lung
(4.9) (12.2) (98.2) (479.0)
2 Brain and CNS Leukemia Colon and rectum Stomach
(2.4) (3.2) (86.6) (449.8)
3  Non-Hodgkin lymphoma Non-Hodgkin lymphoma Liver Colon and rectum
(1.8) (2.9) (65.9) (404.0)
4 Kidney Colon and rectum Thyroid Prostate
(0.5) (2.8) (47.9) (350.5)
5 Testis Stomach Lung Liver
(0.4) (2.5) (41.3) (207.2)
Female
1 Leukemia Thyroid Thyroid Colon and rectum
(4.0) (68.5) (272.4) (198.8)
2 Brain and CNS Breast Breast Stomach
(2.0) (11.2) (119.4) (154.9)
3 Non-Hodgkin lymphoma Cervix uteri Colon and rectum Lung
(1.0) (4.9) (49.9) (129.8)
4 Ovary Stomach Stomach Thyroid
(0.7) (4.3) (43.1) (96.5)
5 Kidney Colon and rectum Lung Liver
(0.5) (2.7) (20.6) (76.7)
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Table 4. Estimated crude and age-standardized cancer mortality rates by gender during 2012 in Korea
CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/un-
specified parts of biliary tract.
Crude incidence rates/100,000 Age-standardized incidence rates/100,000a)
Sites
Both genders Male Female Both genders Male Female
All sites 144.5 178.5 110.4 89.7 132.8 59.0
Lip, oral cavity, and pharynx 2.0 3.0 1.1 1.3 2.1 0.6
Esophagus 2.4 4.5 0.3 1.5 3.3 0.1
Stomach 17.1 22.2 12.1 10.4 16.4 6.1
Colon and rectum 16.2 18.3 14.0 9.8 13.7 7.1
Liver 21.6 32.2 11.0 14.0 23.5 6.0
Gallbladderb) 7.7 7.4 7.9 4.5 5.5 3.8
Pancreas 9.2 9.6 8.8 5.7 7.1 4.5
Larynx 0.4 0.8 0.1 0.3 0.6 0.0
Lung 31.9 46.5 17.2 19.3 34.4 8.7
Breast 4.2 0.1 8.4 2.8 0.0 5.4
Cervix uteri 1.6 - 3.2 1.0 - 1.8
Corpus uteri 0.5 - 1.0 0.3 - 0.6
Ovary 1.9 - 3.9 1.2 - 2.3
Prostate 3.0 6.1 - 1.7 4.7 -
Testis 0.0 0.1 - 0.0 0.1 -
Kidney 1.7 2.2 1.1 1.0 1.6 0.6
Bladder 2.0 2.9 1.1 1.1 2.2 0.5
Brain and CNS 2.1 2.3 1.9 1.5 1.8 1.3
Thyroid 0.7 0.4 1.0 0.4 0.3 0.5
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 2.9 3.4 2.5 1.9 2.6 1.3
Multiple myeloma 1.7 1.7 1.6 1.0 1.2 0.9
Leukemia 3.3 3.8 2.8 2.4 3.0 1.9
Other and ill defined 10.2 11.1 9.2 6.4 8.4 5.0
1. Statistics Korea, 2012 [Internet]. Daejeon: Statistics Korea; 2012 [cited 2012 Jan 14]. Available
from: http://kostat.go.kr.
2. Ministry of Health and Welfare. 2009 annual report of cancer statistics in Korea. Seoul: Ministry
of Health and Welfare; 2011.
3. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in
Korea, 2003-2005. Cancer Res Treat. 2009;41:122-31.
R eferences
incidence, while lung, colorectal, stomach, liver, and pancreas cancers are
estimated to be the most common causes of cancer-related deaths.
Cancer has become an important public health concern in Korea, and
as the population continues to age, the cancer burden will continue to in-
crease. The estimated cancer statistics of the current year given in this re-
port represent an important resource to plan and evaluate cancer-control
programs. The estimates in this report, however, are projected numbers
based on statistical models and may vary from year to year; hence, these
estimates should be used with caution.
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